|Bid||70.04 x 1100|
|Ask||70.08 x 800|
|Day's range||69.03 - 70.18|
|52-week range||63.92 - 88.78|
|Beta (5Y monthly)||0.66|
|PE ratio (TTM)||75.34|
|Forward dividend & yield||0.21 (0.27%)|
|Ex-dividend date||03 May 2022|
|1y target est||85.83|
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.
GENEVA, August 09, 2022--Alcon Reports Second Quarter 2022 Results
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.